SBTi Registry
Explore 1 matching companies with public, verified Science Based Targets commitments.
Data sourced from the Science Based Targets initiative (SBTi).
Show
20
per page| Sector | Region | Near-Term Status | Size | ||||
|---|---|---|---|---|---|---|---|
| Tabuk Pharmaceuticals Manufacturing Company | Pharmaceuticals, Biotechnology and Life Sciences | MENA | Targets set | Large | 5 | Jan 22, 2026 | |
Near-Term Status Targets set Near-Term Classification 1.5°C Near-Term Target Year 2030 Long-Term Status Targets set Net-Zero Status Targets set Net-Zero Year 2050 Sector Pharmaceuticals, Biotechnology and Life Sciences Region MENA Organization Type Corporate Location Saudi Arabia Company Size Large Target Statement Overall Net-Zero Target: Tabuk Pharmaceuticals Manufacturing Company commits to achieve net-zero greenhouse gas emissions across the value chain by 2050. Near-Term Targets: Tabuk Pharmaceuticals Manufacturing Company commits to reduce absolute scope 1 and 2 GHG emissions 50.0% b… Stakeholders Maysara Rabah Chief Technical Officer Saad Stephan Chief Financial Officer Supply Chain Head Procurement Manager Supply Chain and Procurement Officer | |||||||
Show
20
per pageTurn Commitments Into Impact
Thousands of companies have set public Scope 3 emissions-reduction targetsthrough SBTi, but few have the tools to deliver on them. Carbon3 gives you the infrastructure to plan, track, and execute the supply-chain decarbonization work behind your commitment, turning a public pledge into measurable progress. See how it works.